Cardiovascular Systems Unveils New Data from CONFIRM Study Series at the New Cardiovascular Horizons Conference
June 06 2013 - 10:00AM
Business Wire
Subanalysis of CONFIRM Data Highlights
Orbital Atherectomy’s Safety in Treating PAD within Claudicant,
CLI, and Renal Disease Patient Populations
- Plaque modification with orbital
atherectomy resulted in similar low procedural complication rates
for both patients with and without renal disease
- Both claudicants and critical limb
ischemia patient groups had low rates of procedural events,
regardless of arterial calcium burden
Cardiovascular Systems (NASDAQ:CSII)
Historical Stock Chart
From Aug 2024 to Sep 2024
Cardiovascular Systems (NASDAQ:CSII)
Historical Stock Chart
From Sep 2023 to Sep 2024
